Prelude Capital Management’s DexCom DXCM Stock Holding History

Prelude Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-73,200	Closed	-$1.05M	–	1558
2017 Q4	$1.05M	Buy	73,200 +12,000	+20%	+$156K	0.08%	248
2017 Q3	$749K	Sell	61,200 -7,200	-11%	-$127K	0.07%	292
2017 Q2	$1.25M	Sell	68,400 -14,000	-17%	-$259K	0.12%	184
2017 Q1	$1.75M	Buy	82,400 +27,200	+49%	+$531K	0.17%	147
2016 Q4	$824K	Buy	+55,200	New	+$978K	0.1%	239

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Prelude Capital Management's DXCM Position: Q2 2026 in Review

Prelude Capital Management reduced its DexCom (DXCM) stake by 30% in Q2 2026, selling an estimated $112K and leaving 3,857 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #850.

Prelude Capital Management first reported a position in DXCM in Q4 2014 and has held it in 26 quarters since. The position peaked at $2.71M in Q1 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Prelude Capital Management held 3,857 shares of DexCom worth $260K as of Q2 2026.
Prelude Capital Management sold 1,686 DexCom shares in Q2 2026, an estimated $112K.
DexCom made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #850 holding.
Prelude Capital Management first reported a position in DexCom in Q4 2014 and has held it in 26 quarters since.
Prelude Capital Management's DexCom position peaked at $2.71M in Q1 2022.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.